{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:40:32Z","timestamp":1788212432484,"version":"build-2803163510"},"reference-count":27,"publisher":"FapUNIFESP (SciELO)","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.2022d689","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T12:07:43Z","timestamp":1669032463000},"page":"1345-1357","source":"Crossref","is-referenced-by-count":22,"title":["Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex"],"prefix":"10.1590","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3718-1442","authenticated-orcid":false,"given":"Ant\u00f4nio","family":"Silvinato","sequence":"first","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-2866","authenticated-orcid":false,"given":"Idevaldo","family":"Floriano","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-5207","authenticated-orcid":false,"given":"Wanderley Marques","family":"Bernardo","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o M\u00e9dica Brasileira,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2022,10]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5603\/PJNNS.a2020.0059","article-title":"Predictors of remission in patients with epilepsy","volume":"54","author":"W\u0119\u017cyk K","year":"2020","journal-title":"Neurol Neurochir Pol"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan P","year":"2010","journal-title":"Epilepsia"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0883073817714394","article-title":"Early diagnosis and treatment of Lennox-Gastaut syndrome","volume":"32","author":"Resnick T","year":"2017","journal-title":"J Child Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/epi.12567","article-title":"Lennox-Gastaut syndrome: a consensus approach to differential diagnosis","volume":"55","author":"Bourgeois BFD","year":"2014","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/epi.12732","article-title":"The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome","volume":"55","author":"Montouris GD","year":"2014","journal-title":"Epilepsia"},{"issue":"1 Epilepsy","key":"ref6","first-page":"60","article-title":"Infantile, childhood, and adolescent epilepsies","volume":"22","author":"Wirrell E","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/B978-0-444-52891-9.00065-8","article-title":"Dravet syndrome (severe myoclonic epilepsy in infancy)","volume":"111","author":"Dravet C","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40272-016-0171-7","article-title":"Pharmacotherapy for Dravet syndrome","volume":"18","author":"Wallace A","year":"2016","journal-title":"Paediatr Drugs"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup H","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky O","year":"2014","journal-title":"Epilepsia"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/epi.12635","article-title":"The case for assessing cannabidiol in epilepsy","volume":"55","author":"Cilio MR","year":"2014","journal-title":"Epilepsia"},{"issue":"71","key":"ref12","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","journal-title":"BMJ"},{"key":"ref14","series-title":"What is GRADE?"},{"key":"ref15","series-title":"GRADE your evidence and improve your guideline development in health care"},{"key":"ref16","series-title":"Version 5.4. The Cochrane Collaboration","year":"2020"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMc1708349","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"377","author":"Devinsky O","year":"2017","journal-title":"N Engl J Med"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1212\/WNL.0000000000005254","article-title":"Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome","volume":"90","author":"Devinsky O","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial","volume":"77","author":"Miller I","year":"2020","journal-title":"JAMA Neurol"},{"issue":"20","key":"ref20","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome","volume":"378","author":"Devinsky O","year":"2018","journal-title":"N Engl J Med"},{"issue":"10125","key":"ref21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele EA","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial","volume":"78","author":"Thiele EA","year":"2021","journal-title":"JAMA Neurol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/epi.17036","article-title":"Add-on cannabidiol in patients with Dravet syndrome: results of a long-term open-label extension trial","volume":"62","author":"Scheffer IE","year":"2021","journal-title":"Epilepsia"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/epi.17000","article-title":"Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: results of a long-term open-label extension trial","volume":"62","author":"Patel AD","year":"2021","journal-title":"Epilepsia"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/epi.17150","article-title":"Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: an open-label extension trial","volume":"63","author":"Thiele EA","year":"2022","journal-title":"Epilepsia"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","journal-title":"PLoS Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JAC","year":"2016","journal-title":"BMJ"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302022001001345&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T12:08:10Z","timestamp":1669032490000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302022001001345&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["S0104-42302022001001345"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.2022d689","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}